Cellid Co., Ltd. is engaged in developing immunotherapeutic vaccines. The company was founded on December 1, 2006 and is headquartered in Seoul, South Korea.
The current price of 299660 is 6,180 KRW — it has decreased by −3.59% in the past 24 hours. Watch CELLID CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CELLID CO., LTD. stocks are traded under the ticker 299660.
299660 stock has risen by 5.64% compared to the previous week, the month change is a −19.74% fall, over the last year CELLID CO., LTD. has showed a 57.98% increase.
299660 reached its all-time high on Jul 9, 2021 with the price of 123,180 KRW, and its all-time low was 1,730 KRW and was reached on Jul 22, 2024. View more price dynamics on 299660 chart. See other stocks reaching their highest and lowest prices.
299660 stock is 10.88% volatile and has beta coefficient of 0.82. Track CELLID CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is CELLID CO., LTD. there?
Today CELLID CO., LTD. has the market capitalization of 135.27 B, it has decreased by −8.32% over the last week.
299660 net income for the last quarter is −2.61 B KRW, while the quarter before that showed −3.29 B KRW of net income which accounts for 20.61% change. Track more CELLID CO., LTD. financial stats to get the full picture.
No, 299660 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 23, 2024, the company has 58.00 employees. See our rating of the largest employees — is CELLID CO., LTD. on this list?
Like other stocks, 299660 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELLID CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CELLID CO., LTD. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CELLID CO., LTD. stock shows the neutral signal. See more of CELLID CO., LTD. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.
